This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on. The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations.
These countries offer competitive salaries, a lower cost of living compared to other major tech hubs, and better opportunities for quality of life and work-life balance. The Netherlands The Netherlands is home to a rapidly growing tech industry, in particular, in Amsterdam, which boasts several innovation hubs, according to EuroNews.
In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” How patent intel can reveal emerging innovations. From here, the biotech world is your oyster.
By simulating various design scenarios, GenAI accelerates the time it takes to bring new products to market, giving companies a competitive edge. Generative AI in Healthcare and Biotech In healthcare and biotechnology, GenAI is advancing drug discovery, diagnostics, and personalized medicine.
Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 In 2021, Spinraza sales reached $1.9
Hengrui has transitioned from a generic drug manufacturer to a major player in oncology, immunotherapy, and innovative treatments, investing heavily in global R&D infrastructure. Owned by Globe Fintech Innovations (Mynt), GCash has over 80 million users and dominates the countrys mobile payments, lending, and financial services space.
Within the healthcare industry, healthcare equipment continues to outperform (refer to the graph below) driven by the urgent need for innovative care delivery in new or alternative settings and expedited recovery of demand especially for elective procedures. Sponsor deals rebounded exceptionally.
2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. M&A Trends by Industry Healthcare The COVID-19 pandemic ushered in a wave of unprecedented innovation, progress, and transformation to the healthcare industry in 2020.
As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. Now integrated into nearly every industry, genAI is fast becoming a must-have for any firm that aims to get the competitive edge.
As leaders in competitive strategy consulting, serving the life sciences community for the last 17 years, Sedulo Group can help you: Build a comprehensive view of the current and future competitive landscape. Obtain details on competitor clinical trial locations. Assess and benchmark enrollment timing.
Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.
Market Analysis : A valuable tool for conducting market research , as it can analyze large volumes of market data, predict market trends, analyze customer preferences, and provide a snapshot of the competitive landscape. Forecasting Analysis : Analyze financial data to generate potential forecasts.
2020 and 2021 were marked by increased innovation, accelerated growth, and workforce expansion. Inflationary pressures are forecasted to ease and new innovations are capturing the attention of consumers, investors, and executives across various industries. As we navigate 2024, the landscape appears positioned for a triumphant comeback.
We believe that this focus on accessibility and sustainability represents an alternative and attractive opportunity in supporting innovative solutions for global healthcare challenges. This renewed interest in rare disease therapeutics can be attributed to the U.S. Want to dig even deeper into the top takeaways from J.P.
The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?
In today’s fast-paced and ever-evolving business landscape, staying ahead of the competition is more challenging yet more crucial than ever. Having a dedicated and comprehensive competitor analysis framework is critical, as is the ability to access all the competitive information you need in one place.
Ken served on the Board of Directors of Revionics between 2007-2011 and as Chief Scientist & VP of Innovations at SAP AG between 2006-2007. Tim Ouimet Founder & Board Observer Tim Ouimet is a Founder and Board Member at Engage3 and is a recognized industry innovator in retail pricing strategies.
Many IT leaders today are focused more on security management as well as improving IT operations and systems performance than they are on top-line and strategic activities such as driving business innovation, identifying competitive differentiation opportunities, and even working on business strategy.
CEOs, CIOs and CFOs are finding that deep tech is actively driving business innovation and profitability. Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products. CRISPR) for personalized medicine and drought-resistant crops.
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. I’ve had many great positions throughout my career, in many different industries, from biotech to pharma to tech software companies, and currently at a medical device company.
billion acquisition of Carmot Therapeutics, a clinical-stage biotechnology company with three GLP-1 assets in clinical production, including its CT-388 lead GLP-1 asset, in the hopes of gaining a competitive footing among Novo Nordisk and Eli Lilly’s products currently on the market (Ozempic, Wegovy, and Mounjaro, respectively).
According to Synopsys, customers are feeling optimistic about the acquisition, as the combined company will be able to drive innovation across industries by addressing the growing need for integrated system design solutions. Streamline your research workflow, gain the competitive edge, and uncover new opportunities with AlphaSense.
Boston’s innovation business ecosystem—from biotech startups in Kendall Square to fintech firms downtown—relies heavily on quality consumer insights. This modern approach aligns perfectly with Boston’s innovation-driven business culture.
From biotech startups in Torrey Pines to craft breweries in North Park, San Diego businesses rely on solid consumer insights to guide their decisions. Attest – Best for fast, reliable consumer and market insights Attest revolutionizes market research through an innovative combination of advanced platform and expert research support.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content